Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation

Acute exacerbations of interstitial lung disease present as clinical deteriorations, with progressive hypoxemia and parenchymal consolidation not related to infection, heart failure or thromboembolic disease. Following single lung transplantation, patients receive maintenance immunosuppression, whic...

Full description

Saved in:
Bibliographic Details
Main Authors: Dawei Yang, Jennifer M Wilson, Chunxue Bai, John Yee, Pearce G Wilcox, Nasreen Khalil, Robert D Levy
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/2012/258485
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561318442303488
author Dawei Yang
Jennifer M Wilson
Chunxue Bai
John Yee
Pearce G Wilcox
Nasreen Khalil
Robert D Levy
author_facet Dawei Yang
Jennifer M Wilson
Chunxue Bai
John Yee
Pearce G Wilcox
Nasreen Khalil
Robert D Levy
author_sort Dawei Yang
collection DOAJ
description Acute exacerbations of interstitial lung disease present as clinical deteriorations, with progressive hypoxemia and parenchymal consolidation not related to infection, heart failure or thromboembolic disease. Following single lung transplantation, patients receive maintenance immunosuppression, which could mitigate the development of acute exacerbations in the native lung. A 66-year-old man with fibrotic, nonspecific interstitial pneumonitis presented with fever, hypoxemia and parenchymal consolidation limited to the native lung four years after single lung transplantation. Investigations were negative for infection, heart failure and thromboembolic disease. The patient worsened over the course of one week despite broad-spectrum antimicrobial therapy, but subsequently improved promptly with augmentation of prednisone dosed to 50 mg daily and addition of N-acetylcysteine. Hence, the patient fulfilled the criteria for a diagnosis of an acute exacerbation of pulmonary fibrosis in his native lung. Clinicians should consider acute exacerbation of parenchymal lung disease of the native lung in the differential diagnosis of progressive respiratory deterioration following single lung transplantation for pulmonary fibrosis.
format Article
id doaj-art-cdb453d013e74b56995e1bd4ca9df297
institution Kabale University
issn 1198-2241
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-cdb453d013e74b56995e1bd4ca9df2972025-02-03T01:25:24ZengWileyCanadian Respiratory Journal1198-22412012-01-01191e3e410.1155/2012/258485Exacerbation of Pulmonary Fibrosis Following Single Lung TransplantationDawei Yang0Jennifer M Wilson1Chunxue Bai2John Yee3Pearce G Wilcox4Nasreen Khalil5Robert D Levy6Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDivision of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaBritish Columbia Transplant, Vancouver, British Columbia, CanadaDivision of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDivision of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaDivision of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaAcute exacerbations of interstitial lung disease present as clinical deteriorations, with progressive hypoxemia and parenchymal consolidation not related to infection, heart failure or thromboembolic disease. Following single lung transplantation, patients receive maintenance immunosuppression, which could mitigate the development of acute exacerbations in the native lung. A 66-year-old man with fibrotic, nonspecific interstitial pneumonitis presented with fever, hypoxemia and parenchymal consolidation limited to the native lung four years after single lung transplantation. Investigations were negative for infection, heart failure and thromboembolic disease. The patient worsened over the course of one week despite broad-spectrum antimicrobial therapy, but subsequently improved promptly with augmentation of prednisone dosed to 50 mg daily and addition of N-acetylcysteine. Hence, the patient fulfilled the criteria for a diagnosis of an acute exacerbation of pulmonary fibrosis in his native lung. Clinicians should consider acute exacerbation of parenchymal lung disease of the native lung in the differential diagnosis of progressive respiratory deterioration following single lung transplantation for pulmonary fibrosis.http://dx.doi.org/10.1155/2012/258485
spellingShingle Dawei Yang
Jennifer M Wilson
Chunxue Bai
John Yee
Pearce G Wilcox
Nasreen Khalil
Robert D Levy
Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
Canadian Respiratory Journal
title Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
title_full Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
title_fullStr Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
title_full_unstemmed Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
title_short Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
title_sort exacerbation of pulmonary fibrosis following single lung transplantation
url http://dx.doi.org/10.1155/2012/258485
work_keys_str_mv AT daweiyang exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT jennifermwilson exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT chunxuebai exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT johnyee exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT pearcegwilcox exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT nasreenkhalil exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation
AT robertdlevy exacerbationofpulmonaryfibrosisfollowingsinglelungtransplantation